Literature DB >> 9027322

Interleukin-2 (IL-2) and IL-6 regulate c-fos protooncogene expression in human pituitary adenoma explants.

M P Pereda1, V Goldberg, A Chervín, G Carrizo, A Molina, J Andrada, J Sauer, U Renner, G K Stalla, E Arzt.   

Abstract

We have previously shown that interleukin-2 (IL-2) and IL-6, which are expressed in the anterior pituitary, affect anterior pituitary cell proliferation in normal rats and cell lines. Here we examined their effects on the c-fos expression by human anterior pituitary adenomas. Adenoma cells in culture do not express c-fos mRNA. In adenoma explants, however, c-fos expression was detected and was regulated by IL-2 or IL-6. In different tumors (ACTH-, PRL-, GH-secreting and non functioning adenomas), these interleukins had inhibitory or stimulatory effects but the kind of response does not seem to be associated to tumor type or size. Using blocking antibodies, we observed that intrinsic IL-2 and IL-6 regulate c-fos expression in the same way. Our data suggest that IL-2 and IL-6 are not only involved in the regulation of pituitary adenoma function but may also, given the role of c-fos in cell proliferation, be implicated in the development of human pituitary adenomas.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9027322     DOI: 10.1016/s0303-7207(96)03924-x

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

Review 1.  gp130 cytokine signaling in the pituitary gland: a paradigm for cytokine-neuro-endocrine pathways.

Authors:  E Arzt
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

2.  Spontaneous and cytokine regulated c-fos gene expression in rheumatoid synovial cells: resistance to cytokine stimulation when the c-fos gene is overexpressed.

Authors:  K Shimizu; H Kawasaki; T Morisawa; M Nakamura; E Yamamoto; N Yoshikawa; M Doita; K Shiozawa; S Yonehara; K Chihara; S Shiozawa
Journal:  Ann Rheum Dis       Date:  2000-08       Impact factor: 19.103

3.  Inhibition of estrogen-induced pituitary tumor growth and angiogenesis in Fischer 344 rats by the matrix metalloproteinase inhibitor batimastat.

Authors:  Slawomir A Mucha; Gabriela Meleń-Mucha; Andrzej Godlewski; Henryk Stepień
Journal:  Virchows Arch       Date:  2007-01-18       Impact factor: 4.064

4.  Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk.

Authors:  Marcelo Paez-Pereda; Damiana Giacomini; Damian Refojo; Alberto Carbia Nagashima; Ursula Hopfner; Yvonne Grubler; Alberto Chervin; Victoria Goldberg; Rodolfo Goya; Shane T Hentges; Malcolm J Low; Florian Holsboer; Gunter K Stalla; Eduardo Arzt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

5.  N-(2-hydroxy phenyl) acetamide produces profound inhibition of c-Fos protein and mRNA expression in the brain of adjuvant-induced arthritic rats.

Authors:  Huma Jawed; Siddiqua Jamall; Syed Uzair A Shah; Kahkashan Perveen; Farina Hanif; Shabana U Simjee
Journal:  Mol Cell Biochem       Date:  2013-11-02       Impact factor: 3.396

6.  Autocrine IL-6 mediates pituitary tumor senescence.

Authors:  Melanie Sapochnik; Mariana R Haedo; Mariana Fuertes; Pablo Ajler; Guillermo Carrizo; Andrés Cervio; Gustavo Sevlever; Günter K Stalla; Eduardo Arzt
Journal:  Oncotarget       Date:  2017-01-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.